Entrada Therapeutics (TRDA) Prepaid Assets (2020 - 2026)
Entrada Therapeutics' (TRDA) quarterly Prepaid Assets came in at $11.2 million in Q1 2026, down 39.76% year-on-year from $18.6 million in Q1 2025, and up 28.75% quarter-over-quarter from $8.7 million in Q4 2025.
Entrada Therapeutics (TRDA) Prepaid Assets (2020 - 2026) Analysis & Trends
Entrada Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 39.76% year-over-year to $11.2 million in Q1 2026; TTM through Mar 2026 was $11.2 million, a 39.76% decrease from a year earlier, with the FY2025 full-year figure at $8.7 million, down 46.71% from the prior year.
- Prepaid Assets improved to $11.2 million in Q1 2026 per TRDA's latest filing, from $8.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $24.4 million in Q3 2023 and bottomed at $8.7 million in Q4 2025.
- The 5-year median for Prepaid Assets is $12.1 million (2024), against an average of $13.8 million.
- Across the five-year window, Prepaid Assets soared 1316.19% in 2022 and slumped 46.71% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $21.2 million in 2022, then slumped by 43.66% to $11.9 million in 2023, then jumped by 37.21% to $16.4 million in 2024, then slumped by 46.71% to $8.7 million in 2025, then rose by 28.75% to $11.2 million in 2026.
- Per Business Quant, the three latest TRDA Prepaid Assets figures stand at $11.2 million (Q1 2026), $8.7 million (Q4 2025), and $10.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Entrada Therapeutics | 253.11 Mn | 253.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.23 Mn |
| Dec 31, 2025 | 8.72 Mn |
| Sep 30, 2025 | 10.22 Mn |
| Jun 30, 2025 | 13.95 Mn |
| Mar 31, 2025 | 18.63 Mn |
| Dec 31, 2024 | 16.36 Mn |
| Sep 30, 2024 | 13.39 Mn |
| Jun 30, 2024 | 12.12 Mn |
| Mar 31, 2024 | 9.24 Mn |
| Dec 31, 2023 | 11.92 Mn |
| Sep 30, 2023 | 24.44 Mn |
| Jun 30, 2023 | 9.66 Mn |
| Mar 31, 2023 | 16.21 Mn |
| Dec 31, 2022 | 21.16 Mn |
| Sep 30, 2022 | 19.16 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 8.81 Mn |
| Dec 31, 2021 | 7.64 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Dec 31, 2020 | 904,000.00 |